Taking all together, the transient knockdown of Smn in zebrafish recapitulates many aspects of SMA disease and allows for the identification of novel SMA modifiers that could be useful as therapeutic targets. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.